The DOI matches its Crossref record.
Toxicity of high‐dose flurazepam in the elderly
Abstract
To assess the potential hazards of flurazepam (Dalmane) therapy of insomnia in the elderly, the relation of dosage and patient age to the frequency of flurazepam‐attributed adverse reactions was studied in 2,542 hospitalized medical patients. Adverse reactions, predominantly unwanted residual drowsiness, were reported in 78 flurazepam recipients (3.1%). None of the adverse reactions were serious. The frequency of reported toxicity increased with average daily dose, ranging from 1.3% among those receiving less than 15 mg/day to 12.3% at doses of 30 mg/day or more (p < 0.001). Toxicity increased with age, progressively from 1.9% among those under 60 to 7.1 % among those 80 or over (p < 0.001). Unwanted effects of high‐dose flurazepam were observed much more commonly in the elderly. Only 2.0% of those 70 years of age or older experienced adverse reactions at doses under 15 mg/day, as opposed to 39.0% at 30 mg or more per day. Low doses of flurazepam appear to be safe for elderly individuals, but they are susceptible to unwanted central nervous system depression at high doses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,000
Jerram, T. C. (1981) · Side Effects of Drugs Annual · doi:10.1016/s0378-6080(81)80009-8 · Cited by 690
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
Benzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Self-citationReview of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373
Rembacken, B., Hassan, C., Riemann, J., Chilton, A., Rutter, M., Dumonceau, J.-M., Omar, M., & Ponchon, T. (2012) · Endoscopy · doi:10.1055/s-0032-1325686 · Cited by 333
Adverse Drug Reactions Associated with Global Cognitive Impairment in Elderly Persons
LARSON, E. B., KUKULL, W. A., BUCHNER, D., & REIFLER, B. V. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-169 · Cited by 328
The Ambiguous Relation between Aging and Adverse Drug Reactions
Gurwitz, J. H., & Avorn, J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-11-956 · Cited by 313
Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.892 · Cited by 312
Postoperative Delirium in the Elderly
Parikh, S. S., & Chung, F. (1995) · Anesthesia & Analgesia · doi:10.1097/00000539-199506000-00027 · Cited by 300
Is Age an Independent Risk Factor of Adverse Drug Reactions in Hospitalized Medical Patients?*
Carbonin, P., Bernabei, R., & Sgadari, A. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02875.x · Cited by 292
Drug Use in the Elderly: A Review of Problems and Special Considerations
Vestal, R. E. (1978) · Drugs · doi:10.2165/00003495-197816040-00004 · Cited by 287
OUSLANDER, J. G. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-6-711 · Cited by 281
Sensitivity to triazolam in the elderly
Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242403 · Cited by 258
Self-citationImplications of Altered Drug Disposition in the Elderly: Studies of Benzodiazepines
Greenblatt, D. J., Shader, R. I., & Harmatz, J. S. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03246.x · Cited by 102
Self-citationThe geriatric population and psychiatric medication
Varma, S., Sareen, H., & Trivedi, J. (2010) · Mens Sana monographs · doi:10.4103/0973-1229.58818 · Cited by 27
Behavioral Toxicity of Psychiatric Drugs
Perl, M., Hall, R. C. W., & Gardner, E. R. (1980) · Psychiatric Presentations of Medical Illness · doi:10.1007/978-94-011-7677-4_18 · Cited by 6
Metadata
- Authors
- Greenblatt, D. J., Allen, M. D., & Shader, R. I.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1977-03
- Volume
- 21
- Issue
- 3
- Pages
- 355-361
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W182717727
- Cited by
- 244
- References
- 0
- FWCI
- 29.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.